The Open Material Transfer Agreement, or OpenMTA, was developed as a collaborative effort led by the BioBricks Foundation and OpenPlant to make research materials available without any royalties or recipient-based restrictions and to provide for a larger scope of use. Addgene is supportive of these efforts, because they promote accessibility and eliminate/reduce sharing barriers--some of the very goals upon which Addgene was founded.
Accordingly, Addgene is making the OpenMTA one of the available material transfer agreement options for distribution of your materials to industry and academia; provided, amongst other things, that your technology transfer or other legal office approves of such distribution to any customer, including industry, and that the material is not restricted by any third party rights.
If you are interested in potentially making your materials available under the OpenMTA to your colleagues in both industry and academia to be used for any lawful purpose, including commercial purposes, please inform your technology transfer or other legal office of your interest and have them contact email@example.com to initiate the requisite deposit agreements.
Please note that availability under the OpenMTA is subject to your institution’s approval and a review of third party intellectual property. If Addgene cannot make your materials available under the OpenMTA to both industry and academia, Addgene can still make your materials available to academia under the UBMTA.